Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
82.20
+5.77 (7.55%)
At close: Feb 6, 2026, 4:00 PM EST
85.01
+2.81 (3.42%)
After-hours: Feb 6, 2026, 7:45 PM EST
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $972.96 million as of February 6, 2026. Its market cap has increased by 567.49% in one year.
Market Cap
972.96M
Enterprise Value
925.41M
1-Year Change
567.49%
Ranking
Category
Stock Price
$82.20
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $972.96M, an increase of 575.81%. That is a compound annual growth rate of 432.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 972.96M | -21.47% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Iovance Biotherapeutics | 1.00B |
| Ventyx Biosciences | 1.00B |
| Vir Biotechnology | 1.00B |
| UroGen Pharma | 999.37M |
| Aktis Oncology | 996.87M |
| ARS Pharmaceuticals | 991.45M |
| Phathom Pharmaceuticals | 984.95M |
| Geron | 976.68M |